LCP
GILD icon

Lamond Capital Partners’s Gilead Sciences GILD Stock Holding History

Lamond Capital Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-120,000
Closed -$11.8M – 12
2015
Q1 		$11.8M Sell
120,000
-15,870
-12% -$1.61M 12.87% 3
2014
Q4 		$12.8M Buy
+135,870
New +$14.1M 8.39% 5
2014
Q3 		– Sell
-173,000
Closed -$14.3M – 15
2014
Q2 		$14.3M Buy
+173,000
New +$13.5M 9.95% 2

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Lamond Capital Partners's GILD Position: Q2 2015 in Review

Lamond Capital Partners sold out of Gilead Sciences (GILD) in Q2 2015, closing a stake of 120,000 shares — an estimated $11.8M sold.

Lamond Capital Partners first reported a position in GILD in Q2 2014 and held it in 3 quarters. The position peaked at $14.3M in Q2 2014. 1,559 funds tracked by Wall St. Rank hold GILD as of Q2 2015.

  • Lamond Capital Partners reported no remaining Gilead Sciences position as of Q2 2015 after selling out during the quarter.
  • Lamond Capital Partners sold 120,000 Gilead Sciences shares in Q2 2015, an estimated $11.8M.
  • Lamond Capital Partners first reported a position in Gilead Sciences in Q2 2014 and held it in 3 quarters.
  • Lamond Capital Partners's Gilead Sciences position peaked at $14.3M in Q2 2014.
  • 1,559 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2015.

Based on Lamond Capital Partners's 13F filing for Q2 2015, filed 7 Aug 2015.